Postprandial hyperglycemia linked to CVD incidence in T2DM

December 28, 2016

(HealthDay)—For patients with type 2 diabetes, postprandial hyperglycemia is associated with incidence of cardiovascular disease (CVD) and all-cause mortality, independently of the mean glycated hemoglobin (HbA1c) level, according to a study published online Dec. 15 in the Journal of Diabetes Investigation.

Toshiko Takao, from the Institute for Adult Diseases at the Asahi Life Foundation in Tokyo, and colleagues examined the impact of postprandial hyperglycemia at clinic visits on the incidence of CVD and all-cause mortality independently of mean HbA1c in a retrospective observational cohort study. Data were included for 646 with type 2 diabetes. Patients underwent initial consultations during 1995 and 1996, had their two-hour post-breakfast blood glucose (2h-PBBG) measured, and were followed for at least one year. Overall, 618 of the patients had no history of CVD at the initial visit and had measured 2h-PBBG until the first CVD onset or censorings. Patients were followed through June 2012.

The researchers found that CVD and death occurred in 78 and 56 patients, respectively. After adjustment for the mean HbA1c, the number of 2h-PBBG measurements, age, sex, and classical risk factors, the mean 2h-PBBG was a significant predictor for CVD incidence and all-cause mortality.

"Postprandial hyperglycemia represented by the mean level of 2h-PBBG at clinic visits is associated with the CVD incidence and all-cause mortality independently of the mean HbA1c level in type 2 patients," the authors write.

Explore further: Incidence of hospitalization for hypoglycemia decreasing

More information: Full Text (subscription or payment may be required)

Related Stories

Incidence of hospitalization for hypoglycemia decreasing

December 3, 2016
(HealthDay)—For patients with type 1 diabetes, the incidence of hospitalization for hypoglycemia (HH) decreased over time in Denmark, with an 8.4 percent annual decrease, according to a study published online Nov. 29 in ...

Follow-up phone calls may boost glycemic control in T2DM

November 19, 2016
(HealthDay)—For patients with type 2 diabetes, follow-up phone calls after a monthly clinic visit could lead to clinically significant change in hemoglobin A1C (HbA1c) levels, according to a study published online Nov. ...

Modest relation between HbA1c, cardiovascular events

September 4, 2015
(HealthDay)—For patients with type 2 diabetes, hemoglobin A1c (HbA1c) is not significantly associated with cardiovascular events, regardless of clinical manifestation of vascular disease, according to a study published ...

Risk of ischemic, hemorrhagic stroke up with type 1 diabetes

December 13, 2016
(HealthDay)—The risks of ischemic and hemorrhagic stroke are increased with type 1 diabetes, with incrementally increasing risks with increasing hemoglobin A1c (HbA1c), according to a study published in the November issue ...

Impact of HbA1c, BMI changes on lipids varies as children age

November 2, 2016
(HealthDay)—As children age, the impact of changes in hemoglobin A1c (HbA1c) and body mass index (BMI) on low-density lipoprotein (LDL) and non-high-density lipoprotein (non-HDL) cholesterol levels increases, according ...

Cumulative incidence of ESRD low in patients with type 1 DM

November 8, 2016
(HealthDay)—Patients with type 1 diabetes diagnosed at age 15 to 27 years have low cumulative incidence of end-stage renal disease (ESRD) and increased mortality during long-term follow-up, according to a study published ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.